101.
The Effects of Ezetimibe/Simvastatin versus Simvastatin Monotherapy on Platelet and Inflammatory Biomarkers in Patients with Metabolic Syndrome
by Miller, Michael
Cardiology, 2013-06, Vol.125 (2), p.74-77
102.
Efficacy and Safety of Ezetimibe Added to Atorvastatin Versus Atorvastatin Uptitration or Switching to Rosuvastatin in Patients With Primary Hypercholesterolemia
by Bays, Harold E., MD
The American journal of cardiology, 2013, Vol.112 (12), p.1885-1895
103.
Lipid Management After First Diagnosis of Coronary Artery Disease: Contemporary Results From an Observational Cohort Study
by Waldeyer, Christoph
Clinical therapeutics, 2017-11, Vol.39 (11), p.2311-2320.e2
104.
How Low is Low Enough?
by Feeman, W.E., MD
The American journal of cardiology, 2017, Vol.120 (2), p.338-338
105.
Prevention of Cataract by Statins
by Kostis, John B., MD
The American journal of cardiology, 2016, Vol.117 (7), p.1196-1196
106.
Effect of Randomized Lipid Lowering With Simvastatin and Ezetimibe on Cataract Development (from the Simvastatin and Ezetimibe in Aortic Stenosis Study)
by Bang, Casper N., MD, PhD
The American journal of cardiology, 2015, Vol.116 (12), p.1840-1844
107.
The Niemann-Pick C1 Like 1 (NPC1L1) Inhibitor Ezetimibe Improves Metabolic Disease Via Decreased Liver X Receptor (LXR) Activity in Liver of Obese Male Mice
by Sugizaki, Taichi
Endocrinology (Philadelphia), 2014-08, Vol.155 (8), p.2810-2819
108.
Effects of Statins on the Development of Cataract-the Long Standing Debate
by Pourafkari, Leili, MD
The American journal of cardiology, 2016, Vol.117 (3), p.489-490
109.
Statin-associated Muscle Symptoms and SLCO1B1 rs4149056 Genotype in Patients with Familial Hypercholesterolemia
by Khine, Htet, M.D
The American heart journal, 2015, Vol.179, p.1-9
110.
Efficacy and safety of ezetimibe co-administered with simvastatin compared with atorvastatin in adults with hypercholesterolemia
by Ballantyne, Christie M
The American journal of cardiology, 2004, Vol.93 (12), p.1487-1494
111.
Effect of ezetimibe monotherapy on the concentration of lipoprotein subfractions in patients with primary dyslipidaemia
by Kalogirou, Mihalis
Current medical research and opinion, 2007-05, Vol.23 (5), p.1169-1176
112.
Efficacy and Tolerability of Fluvastatin XL 80 mg Alone, Ezetimibe Alone, and the Combination of Fluvastatin XL 80 mg With Ezetimibe in Patients With a History of Muscle-Related Si...
by Stein, Evan A., MD, PhD
The American journal of cardiology, 2008, Vol.101 (4), p.490-496
113.
Cholesterol and Plant Sterol Absorption: Recent Insights
by von Bergmann, Klaus
The American journal of cardiology, 2005, Vol.96 (1), p.10-14
114.
Effect of Lipid-Lowering Treatment on Natural History of Heterozygous Familial Hypercholesterolemia in Past Three Decades
by Elis, Avishay, MD
The American journal of cardiology, 2011, Vol.108 (2), p.223-226
115.
Design and Baseline Characteristics of the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) Study
by Rossebø, Anne B., MD
The American journal of cardiology, 2007, Vol.99 (7), p.970-973
116.
New simple spectrophotometric method for determination of the binary mixtures (atorvastatin calcium and ezetimibe; candesartan cilexetil and hydrochlorothiazide) in tablets
by Belal, Tarek S
Journal of pharmaceutical analysis, 2013-04, Vol.3 (2), p.118-126
117.
Modulation of cholesterol-related gene expression by ergosterol and ergosterol-enriched extracts obtained from Agaricus bisporus
by Gil-Ramírez, Alicia
European journal of nutrition, 2015-05-07, Vol.55 (3), p.1041-1057
118.
Pooled Analyses of Effects on C-Reactive Protein and Low Density Lipoprotein Cholesterol in Placebo-Controlled Trials of Ezetimibe Monotherapy or Ezetimibe Added to Baseline Statin...
by Pearson, Thomas A., MD, PhD
The American journal of cardiology, 2009, Vol.103 (3), p.369-374
119.
Effect on Fasting Serum Glucose Levels of Adding Ezetimibe to Statins in Patients With Nondiabetic Hypercholesterolemia
by Toth, Peter P
The American journal of cardiology, 2016-12-15, Vol.118 (12), p.1812-1820
120.
Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: A 12-week, multicenter, randomized, double-blind, controlled tr...
by Huijgen, Roeland, MD
Clinical therapeutics, 2010, Vol.32 (4), p.615-625
